OptiNose (OPTN) Reports Q2 Loss, Lags Revenue Estimates

OptiNose (OPTN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 12.50%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.10 per share when it actually produced a loss of $0.12, delivering a surprise of -20%. Over the last four quarters, the ...